Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 33
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: N16INM
Study First Received: October 24, 2016
Last Updated: February 7, 2017
Estimated Primary Completion Date: September 2018
Primary Outcome Measures:
Disease Controle Rate (DCR) at 12 weeks|Safety: the incidence of adverse events, serious adverse events, deaths and laboratory abnormalities.|Disease Controle Rate (DCR) at 6 months|Progression Free Survival (PFS)|Overall Survival (OS)|Overall Response Rate (ORR)
Sponsors and Collaborators:
The Netherlands Cancer Institute|Bristol-Myers Squibb
Website Link: https://ClinicalTrials.gov/show/NCT03048474
